Related Experiment Video
Updated: Jul 9, 2026

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
Published on: May 15, 2017
Comprehensive evaluation of cyflumetofen between strawberry cultivation and processing factors: Occurrence,
Shutian Liu1, Xin Ren2, Bin Zhang3
1State Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing 100000, PR China; College of Horticulture and Landscape Architecture, Tianjin Agricultural University, Tianjin 300384, PR China.
Abstract:
In this study, the residue dynamics of cyflumetofen (CYF) and its metabolite 2-trifluoromethylbenzoic acid (B-1) throughout strawberry cultivation and processing were investigated using high-performance liquid chromatography-tandem mass spectrometry. This technique enabled precise separation and identification of cyflumetofen (CYF, 2.12 min) and its metabolite B-1 (1.35 min), with LOQs of 0.001 mg/kg for both. CYF and B-1 remained stable under frozen and dark storage conditions, persisting in strawberry tissues for up to 59 days. Affected by climate, environment, and strawberry variety, initial CYF residues during cultivation were 0.20-0.46 mg/kg (degradation half-life:1.92-7.07 days), with final residues stabilizing at 0.03-0.36 mg/kg. Additionally, 0.87-50.0% of CYF metabolized into B-1, both showing toxicological effects. Washing reduced their residues in fresh strawberries. Dietary risk assessments (deterministic models) showed processing significantly reduced the dietary risk of strawberry jam to 0.0013-0.0094%.
More Related Videos
12:32Colletotrichum fioriniae Development in Water and Chloroform-based Blueberry and Cranberry Floral Extracts
Published on: April 12, 2019
08:22Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
Published on: December 22, 2023
Related Concept Videos
Factors Influencing Bioavailability: First-Pass Elimination
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Bioavailability: Influencing Factors
Pharmacokinetics: Drug–Food and Drug–Viral Interactions